Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Niagen Bioscience (NAGE) Long-Term Debt Issuances (2016)

Niagen Bioscience (NAGE) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$2.5 million as the latest value for Q4 2016.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to -$2.5 million in Q4 2016 year-over-year; TTM through Sep 2019 was -$2.5 million, a N/A change, with the full-year FY2019 number at $10.0 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was -$2.5 million for Q4 2016 at Niagen Bioscience.
  • In the past five years, Long-Term Debt Issuances ranged from a high of -$2.5 million in Q4 2016 to a low of -$2.5 million in Q4 2016.